Glenview Trust co Has $51.01 Million Stock Holdings in Procter & Gamble Company (The) $PG

Key Points

• Glenview Trust Co has reduced its holdings in Procter & Gamble by 0.8% to a total of approximately $51.01 million, representing about 1.0% of its investment portfolio.
• Institutional investors and hedge funds collectively own 65.77% of Procter & Gamble's stock, indicating strong institutional interest in the company.
• Procter & Gamble reported earnings of $1.48 per share, exceeding expectations, with a total revenue of $20.89 billion for the quarter.

Glenview Trust co lowered its position in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 0.8% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 299,314 shares of the company's stock after selling 2,436 shares during the period. Procter & Gamble accounts for 1.0% of Glenview Trust co's portfolio, making the stock its 24th largest holding. Glenview Trust co's holdings in Procter & Gamble were worth $51,009,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in PG. Capital A Wealth Management LLC acquired a new position in Procter & Gamble during the fourth quarter valued at approximately $31,000. Quarry LP acquired a new position in Procter & Gamble during the first quarter valued at approximately $33,000. 10Elms LLP acquired a new position in Procter & Gamble during the fourth quarter valued at approximately $34,000. Mizuho Securities Co. Ltd. grew its holdings in Procter & Gamble by 566.7% during the first quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company's stock valued at $34,000 after purchasing an additional 170 shares during the last quarter. Finally, Sunbeam Capital Management LLC acquired a new position in Procter & Gamble during the fourth quarter valued at approximately $34,000. Institutional investors and hedge funds own 65.77% of the company's stock.

Insider Activity

In other Procter & Gamble news, insider Marc S. Pritchard sold 9,849 shares of the stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $1,548,952.23. Following the completion of the transaction, the insider directly owned 182,422 shares in the company, valued at $28,689,507.94. This represents a 5.12% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, COO Shailesh Jejurikar sold 13,039 shares of the stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $2,050,643.53. Following the transaction, the chief operating officer owned 28,036 shares of the company's stock, valued at $4,409,221.72. This represents a 31.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 120,181 shares of company stock valued at $18,918,012. 0.20% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on PG. BNP Paribas reissued an "outperform" rating and issued a $177.00 price objective on shares of Procter & Gamble in a research report on Friday, August 15th. Evercore ISI reissued an "in-line" rating and issued a $170.00 price objective (down from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. Wells Fargo & Company reduced their price objective on Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating for the company in a research report on Wednesday, July 30th. UBS Group set a $180.00 price objective on Procter & Gamble and gave the company a "buy" rating in a research report on Wednesday, July 30th. Finally, JPMorgan Chase & Co. reissued a "neutral" rating and issued a $170.00 price objective (down from $178.00) on shares of Procter & Gamble in a research report on Friday, July 25th. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and seven have given a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $175.12.

Procter & Gamble Stock Performance

PG stock traded down $0.61 during midday trading on Friday, hitting $158.02. The stock had a trading volume of 5,956,120 shares, compared to its average volume of 6,033,143. The firm has a market capitalization of $369.85 billion, a price-to-earnings ratio of 24.27, a P/E/G ratio of 4.19 and a beta of 0.36. Procter & Gamble Company has a 52 week low of $149.91 and a 52 week high of $180.43. The stock has a 50-day simple moving average of $156.21 and a 200 day simple moving average of $161.90. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49.

Procter & Gamble (NYSE:PG - Get Free Report) last issued its earnings results on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, topping the consensus estimate of $1.42 by $0.06. The firm had revenue of $20.89 billion during the quarter, compared to analysts' expectations of $20.79 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.Procter & Gamble's quarterly revenue was up 1.7% compared to the same quarter last year. During the same period last year, the business earned $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities research analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were paid a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a yield of 2.7%. The ex-dividend date was Friday, July 18th. Procter & Gamble's dividend payout ratio is currently 64.98%.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.